Current News Service
Wednesday, September 5, 2018
FOX BIZ NEWS: Here's Why Cara Therapeutics Rose 12.5% in August
Here's Why Cara Therapeutics Rose 12.5% in August
The company announced second-quarter 2018 earnings results and initiated a crucial late-stage clinical trial.
via FOX BUSINESS NEWS https://ift.tt/2Nitda4
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment